Garrett focuses his practice on private equity transactional, portfolio company, and general corporate matters. He represents clients across a broad range of industries including private equity funds, technology, health care, and consumer goods.
Prior to joining Mintz, Garrett served as a legal intern with a biopharmaceutical company focused on developing cancer treatments. He also served as a legal intern with a pharmaceutical company developing medicine to control the expression of genes.
As a business analyst, Garrett worked in supply chain operations with a California-based global information technology company, with a Canadian multinational financial services company, and as a document control officer in the corporate financing division of a Canadian multinational bank.
Experience
- Represented Liberty Power, an independent retail electricity supplier, in its negotiation of a multiyear supply agreement with Boston Energy Trading and Marketing LLC, restructuring of its existing capital structure, and entry into new financing arrangements.
- Represented a national distributed solar developer in its acquisitions of solar energy Project Companies in New York, Massachusetts, New Hampshire, Maryland, Pennsylvania, and Texas.
- Represented cloud computing company Rocket Innovations, Inc. in the sale of Rocketbook, the leading smart reusable notebook brand in the United States, to BIC, a global manufacturing company of disposable consumer products such as stationery, lighters, and shavers.
- Represented Capstone Partners, an investment banking and advisory firm serving middle market companies, in its sale to Huntington Bancshares Incorporated (NASDAQ: HBAN).
- Represented Albireo Pharma, a biotechnology company focused on developing treatments for rare disease, in its sale to French biotechnology firm Ipsen S.A.
- Represented Med-Pharmex, a manufacturer of generic veterinary drugs and portfolio company of private equity firm DW Healthcare Partners, in its sale to Dechra Pharmaceuticals, a British-owned developers and manufacturer of veterinary products.
- Represented XL Fleet Corp., a developer and manufacturer of vehicle electrification solutions, in its de-SPAC merger with Pivotal Investment Corporation II, a special purpose acquisition company.
viewpoints
Restrictive Covenants in Private Equity Transactions
May 14, 2025 | Alert | By Garrett Galvin, David G. Conway, Katya Daniel, Benjamin Ferrucci, Tom J. Pagliarini
Restrictive covenants are unquestionably a significant deal consideration in M&A transactions. In the private equity context, a buyer is focused on restrictive covenants to protect its investment by binding the sellers and other recipients of material deal proceeds to obligations and restrictions for a certain period of time following the transaction. Restrictive covenants serve several purposes and are highly beneficial for a buyer; accordingly, absent any legal limitations and assuming sufficient consideration, a buyer is incentivized to impose restrictive covenants on as many selling parties as possible. However, and not surprisingly, sellers heavily negotiate their post-transaction restrictive covenant obligations to keep their business options as open as possible on a go-forward basis. The conflicting interests of buyers and sellers when it comes to restrictive covenants result in carefully negotiated covenants spread out over multiple transaction documents and employment agreements. This article discusses the common restrictive covenants used in private equity transactions, the importance of such covenants in the key transaction documents, and related enforcement considerations.
Energy & Sustainability Legal Feature — Recently Announced Clean Hydrogen Hub Program Funding
October 13, 2022 | Article | By Garrett Galvin, Alana D. Agron
Read about the Biden-Harris administration’s announcement of $7 billion in funding to create regional clean hydrogen hubs (“H2Hubs”)